Hacker Newsnew | past | comments | ask | show | jobs | submitlogin

Going into a PhD in genetics this fall. I think it's a good analogy, but it's more akin to say, "Factories that are closing don't have steel." To which, I think we'd all say, "Of course."


Don't we already have general knowledge about the molecular machinery that can stop cellular replication?

Wouldn't inhibiting nucleotide production already be explored well for cancer targets?

Isnt the only new thing here that they profiled and used senescent HMEC cells?

It seems they already had pharmaceutical and genetic means to target the protein already.




Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: